Clinical Trial Update: Neoadjuvant Pemetrexed, Carboplatin and Bevacizumab in Unresectable, Locally Advanced Lung Adenocarcinoma [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 trial evaluating neoadjuvant pemetrexed, carboplatin, and bevacizumab in patients with unresectable, locally adv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Adenocarcinoma

Drugs mentioned

• Alimta (pemetrexed)
• Avastin (bevacizumab)
• CARBOPLATIN (Carboplatin)

Snippet

Sponsor: Si-Yu Wang | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED